DE69310768D1 - Neue proteinhaltige partikeln - Google Patents
Neue proteinhaltige partikelnInfo
- Publication number
- DE69310768D1 DE69310768D1 DE69310768T DE69310768T DE69310768D1 DE 69310768 D1 DE69310768 D1 DE 69310768D1 DE 69310768 T DE69310768 T DE 69310768T DE 69310768 T DE69310768 T DE 69310768T DE 69310768 D1 DE69310768 D1 DE 69310768D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- acid sequence
- amino acid
- epitope
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002245 particle Substances 0.000 title abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 229940021993 prophylactic vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929227068A GB9227068D0 (en) | 1992-12-29 | 1992-12-29 | Novel proteinaceous particles |
PCT/GB1993/002656 WO1994014969A1 (en) | 1992-12-29 | 1993-12-24 | Novel proteinaceous particles |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69310768D1 true DE69310768D1 (de) | 1997-06-19 |
DE69310768T2 DE69310768T2 (de) | 1997-12-04 |
Family
ID=10727292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69310768T Expired - Fee Related DE69310768T2 (de) | 1992-12-29 | 1993-12-24 | Neue proteinhaltige partikeln |
Country Status (9)
Country | Link |
---|---|
US (1) | US6060064A (de) |
EP (1) | EP0677111B1 (de) |
JP (1) | JPH08505768A (de) |
AT (1) | ATE153071T1 (de) |
AU (1) | AU5711294A (de) |
DE (1) | DE69310768T2 (de) |
ES (1) | ES2104339T3 (de) |
GB (1) | GB9227068D0 (de) |
WO (1) | WO1994014969A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
US7247297B2 (en) * | 2001-09-14 | 2007-07-24 | The University Of Chicago | Use of DF3/MUC1 regulated expression in gene therapy |
US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
MXPA04002644A (es) | 2001-10-05 | 2004-07-08 | Cytos Biotechnology Ag | Conjugados que portan un peptido de angiotensina y usos de los mismos. |
US20080233181A1 (en) * | 2002-04-12 | 2008-09-25 | Nagy Jon O | Nanoparticle adjuvants for sub-unit vaccines |
US7285289B2 (en) * | 2002-04-12 | 2007-10-23 | Nagy Jon O | Nanoparticle vaccines |
DK1524994T3 (da) | 2002-07-19 | 2011-08-15 | Cytos Biotechnology Ag | Vaccinesammensætninger indeholdende amyloid beta 1-6-antigen-arrays |
US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
KR20050115913A (ko) | 2003-03-26 | 2005-12-08 | 사이토스 바이오테크놀로지 아게 | Melan―a 펩티드 유사체-바이러스-양-입자컨쥬게이트 |
EP1989326A4 (de) | 2006-01-17 | 2009-09-30 | Health Research Inc | Heteroduplex-verfolgungstest |
JP2010508860A (ja) * | 2006-11-15 | 2010-03-25 | フォリア バイオテック インコーポレイテッド | パパイヤモザイクウイルスに基づくインフルエンザ用ワクチン |
CN102014874A (zh) | 2008-03-04 | 2011-04-13 | 流体科技公司 | 免疫调节剂颗粒和治疗方法 |
WO2010025425A1 (en) | 2008-08-29 | 2010-03-04 | Angros Lee H | Multiplexed microscope slide staining apparatus |
EP3187585A1 (de) | 2010-03-25 | 2017-07-05 | Oregon Health&Science University | Cmv-glycoproteine und rekombinante vektoren |
TWI526539B (zh) | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
DK2691530T3 (en) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | CMV GLYCOPROTEIN AND RECOMBINANT VECTORS |
EP2568289A3 (de) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
EP2848937A1 (de) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Verfahren zur Identifizierung neuartiger HIV-1-Immunogene |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
WO2017068077A1 (en) | 2015-10-20 | 2017-04-27 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods and products for genetic engineering |
-
1992
- 1992-12-29 GB GB929227068A patent/GB9227068D0/en active Pending
-
1993
- 1993-12-24 AU AU57112/94A patent/AU5711294A/en not_active Abandoned
- 1993-12-24 US US08/492,076 patent/US6060064A/en not_active Expired - Fee Related
- 1993-12-24 DE DE69310768T patent/DE69310768T2/de not_active Expired - Fee Related
- 1993-12-24 WO PCT/GB1993/002656 patent/WO1994014969A1/en active IP Right Grant
- 1993-12-24 AT AT94902961T patent/ATE153071T1/de not_active IP Right Cessation
- 1993-12-24 EP EP94902961A patent/EP0677111B1/de not_active Expired - Lifetime
- 1993-12-24 JP JP6514974A patent/JPH08505768A/ja active Pending
- 1993-12-24 ES ES94902961T patent/ES2104339T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB9227068D0 (en) | 1993-02-24 |
DE69310768T2 (de) | 1997-12-04 |
EP0677111B1 (de) | 1997-05-14 |
ES2104339T3 (es) | 1997-10-01 |
ATE153071T1 (de) | 1997-05-15 |
WO1994014969A1 (en) | 1994-07-07 |
EP0677111A1 (de) | 1995-10-18 |
JPH08505768A (ja) | 1996-06-25 |
AU5711294A (en) | 1994-07-19 |
US6060064A (en) | 2000-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69310768D1 (de) | Neue proteinhaltige partikeln | |
KR880700076A (ko) | 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법 | |
HUP0202796A2 (en) | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens | |
GB9215780D0 (en) | Peptide compounds | |
PT101052A (pt) | Proteinas hibridas uteis na preparacao de vacinas | |
KR950700758A (ko) | 비-이온성 계면활성제 소포를 함유하는 백신(Vaccines containing non ionic surfactant vesicles) | |
PT97159A (pt) | Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina | |
DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
AU1542695A (en) | Hepatitis b vaccine | |
SG63621A1 (en) | Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines | |
CA2128407A1 (en) | Synthetic peptides for a rubella vaccine | |
WO1997039029A3 (en) | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof | |
AU6393990A (en) | Hiv related peptides | |
ATE79404T1 (de) | Verfahren zur herstellung von hepatitis-b-virus- innenkoerperantigen (hbcag) in hefe. | |
KR950701821A (ko) | 피임 백신(contraceptive vaccine) | |
WO2002051865A3 (fr) | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih | |
Ivanoff et al. | Human immunodeficiency virus antigen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |